The Decision adopted 26 July 2018 (in force as of 28 August 2018) provides criteria for determining how the type of a medical device constituent is to be identified.
Pharma and medical devices
As of 21 April 2018, developers of pharmaceuticals (the Applicants) are required to follow the adopted procedure if they wish to obtain a permit for a clinical trial for their pharmaceuticals.
The state agency responsible for issuing clinical trial permits is the Ministry of Healthcare of the Russian Federation.
The adopted Guideline has been approved for the use by the authorized bodies of the EAEU member states.
The Guideline applies to dosage forms in which the modification of the rate and (or) the place of release of the active ingredient (active substances) in a definite manner is compared with the standard release dosage forms.
As of 15 May 2018, importers and manufacturers of veterinary medicines and feed additives are required to comply with the provisions of the adopted Technical Regulation (TR) on the Safety of Veterinary Medicines and Feed Additives.
The adopted TR applies to ready-to-use chemical-pharmaceutical and biological medicines and feed additives.